Saltar al contenido
Merck

Fatty acid hydrolysis of acyl marinobactin siderophores by Marinobacter acylases.

Biochemistry (2015-01-15)
Michelle P Kem, Hiroaki Naka, Akira Iinishi, Margo G Haygood, Alison Butler
RESUMEN

The marine bacteria Marinobacter sp. DS40M6 and Marinobacter nanhaiticus D15-8W produce a suite of acyl peptidic marinobactin siderophores to acquire iron under iron-limiting conditions. During late-log phase growth, the marinobactins are hydrolyzed to form the marinobactin headgroup with release of the corresponding fatty acid tail. The bntA gene, a homologue of the Pseudomonas aeruginosa pyoverdine acylase gene, pvdQ, was identified from Marinobacter sp. DS40M6. A bntA knockout mutant of Marinobacter sp. DS40M6 produced the suite of acyl marinobactins A-E, without the usual formation of the marinobactin headgroup. Another marinobactin-producing species, M. nanhaiticus D15-8W, is predicted to have two pvdQ homologues, mhtA and mhtB. MhtA and MhtB have 67% identical amino acid sequences. MhtA catalyzes hydrolysis of the apo-marinobactin siderophores as well as the quorum sensing signaling molecule, dodecanoyl-homoserine lactone. In contrast to hydrolysis of the suite of apo-marinobactins by MhtA, hydrolysis of the iron(III)-bound marinobactins was not observed.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Imidazol, ReagentPlus®, 99%
Sigma-Aldrich
Imidazol, ACS reagent, ≥99% (titration)
Sigma-Aldrich
Imidazol, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
Imidazol, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Imidazole buffer Solution, BioUltra, 1 M in H2O
Sigma-Aldrich
Imidazol, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Imidazol, ≥99% (titration), crystalline
Sigma-Aldrich
Imidazol, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Imidazol, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
Imidazol, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Imidazol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Imidazol, ReagentPlus®, 99%, Redi-Dri, free-flowing
Imidazol, European Pharmacopoeia (EP) Reference Standard
Imidazol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Imidazol, Molecular Biology, ≥99% (titration), free-flowing, Redi-Dri